ArticleInternational journal of biological sciences2023

Drug Repurposing Flubendazole to Suppress Tumorigenicity via PCSK9-dependent Inhibition and Potentiate Lenvatinib Therapy for Hepatocellular Carcinoma.

Wenjiao Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.